Muthyam Sowjanya |Cancer | Women Researcher Award

Posted on by ScienceFather

Dr. Muthyam Sowjanya | Cancer | Women Researcher Award

Dr at Vikrama simhapuri university,Ā  India

Sowjanya Muthyam, Ph.D., is a dedicated and highly skilled scientist with 8 years of expertise in immunology, inflammation, molecular biology, cell biology, and biochemistry. Having worked on diverse research projects, including promoting polythene degradation by Spingomonas bacteria and studying bioactive compound production from fungi, Dr. Muthyam seeks a Scientist position to advance industrial, clinical, and translational research.

Profile

Orcid

Education šŸŽ“

Dr. Muthyam holds a Ph.D. in Biotechnology from Andhra University (2014-2019), where her thesis focused on isolating, purifying, and characterizing novel anticancer compounds from Leucas indica flowers. She also completed her M.Sc. in Biotechnology from SRM University (2009-2011), where she studied shell loss in P. monodon and the antiglycation effects of spices. She holds a B.Sc. in Biotechnology, Chemistry, and Computer Applications from Sri Venkateswara University (2006-2009).

Research Experience šŸ’¼

Dr. Muthyam’s doctoral research involved isolating and characterizing bioactive compounds from Leucas indica, revealing an anticancer compound that inhibited cancer cell proliferation, particularly in MCF-7 and HeLa cell lines. Her work involved various techniques like column chromatography, UV, TLC, NMR, and apoptosis assays, contributing significantly to cancer treatment strategies. She also collaborated on projects related to bioremediation and bioactive compound production.

Awards šŸ†

Dr. Muthyam has received the UGC RGNF fellowship as a Junior Research Fellow (2014-2016) and a Senior Research Fellow (2016-2019). She has also mentored graduate and undergraduate students, supervised research projects, and served as a judge for research poster presentations. Her contributions to the field have earned recognition within the scientific community, particularly for her work on novel anticancer compounds.

Research Focus šŸ”

Dr. Muthyam’s primary research focuses on the isolation and characterization of bioactive compounds, with a strong emphasis on anticancer agents. Her work also explores bioremediation strategies, enzyme production, and the application of fungi in industrial processes. Dr. Muthyam is particularly interested in advancing molecular biology, immunology, and biochemistry to develop therapeutics for cancer treatment and environmental sustainability.

Teaching and Mentoring ExperiencešŸ§‘ā€šŸ«

Dr. Muthyam has a solid background in teaching and mentoring, having supervised over 40 graduate students and interns at Andhra University. She has also mentored numerous undergraduate students and evaluated their research poster presentations. Additionally, she is currently serving as a guest faculty member at Vikrama Simhapuri University, where she continues to guide students in research and development.

Conclusion šŸ“

Dr. Sowjanya Muthyam stands out as a promising researcher with a solid academic foundation, innovative research achievements, and a passion for mentoring the next generation of scientists. Her work, particularly in cancer treatment and bioactive compounds, holds immense potential for future clinical and industrial applications. By focusing on expanding her publication record, collaborations, and public engagement, she can significantly enhance her impact in the scientific community. Dr. Muthyam is a strong candidate for the Women Researcher Award, and her continued contributions will undoubtedly advance the fields of biotechnology and molecular medicine.

Publications šŸ“š

  1. Probiotics Contribution to the Development of Aquaculture: A Review
    • Journal: African Journal of Biological Sciences
    • Date: 2024-07-20
    • Contribution: Sowjanya Muthyam

 

  1. Immobilisation of Aspergillus flavus Strain S4 Spores for Optimal Production and Activity of L-Glutaminase
    • Journal: Chelonian Conservation and Biology
    • Date: 2023-11-11
    • Contribution: Sowjanya Muthyam

 

  1. Incidence of White Feces Syndrome (WFS) and Its Management with Herbal Supplements (Allium sativum and Curcuma longa) by Improving the Growth and Gut Health of Shrimp Litopenaeus vannamei (Boone-1931)
    • Journal: IJFANS International Journal of Food and Nutritional Sciences
    • Date: 2023-11-11
    • Contribution: Sowjanya Muthyam

 

  1. Industrial Applications of Alkaline Protease with Novel Properties from Bacillus cereus Strain S8
    • Date: 2023-11-07
    • Contribution: Sowjanya Muthyam

 

  1. Phytochemical Analysis and Antimicrobial Activity of Muntingia calabura
    • Journal: Journal of Chemical Health Risks
    • Date: 2023-11-07
    • Contribution: Sowjanya Muthyam

 

  1. Characterization of Alkaline Protease from Bacillus cereus Strain S8 by In Silico Approach
    • Journal: Chelonian Conservation and Biology
    • Date: 2023-11-02
    • Contribution: Sowjanya Muthyam

 

  1. In Vitro Antibacterial Activity of Flower Extract of Leucas indica
    • Journal: Journal of Advanced Zoology
    • Date: 2023-11-02
    • Contribution: Sowjanya Muthyam

 

  1. Antiglycation Effect of Chillies and Spices Used in Traditional Indian Cuisine
    • Journal: European Journal of Biomedical and Pharmaceutical Sciences
    • Date: 2023-10-22
    • Contribution: Sowjanya Muthyam

 

  1. Purification, Characterization Studies of L-Glutaminase from Aspergillus flavus Strain S4
    • Journal: Journal of Advanced Zoology
    • Date: 2023-10-01
    • Contribution: Sowjanya Muthyam

 

  1. Probiotics and Their Prolific Role in Shrimp Farming Practices
  • Date: 2022-12-26
  • Contribution: Sowjanya Muthyam

 

Angelika Długosz-Pokorska | cancer research | Women Researcher Award

Posted on by ScienceFather

Ā Dr. Angelika Długosz-Pokorska | cancer research |Women Researcher Award

Ā Dr at Medical University of ÅĆ³dÅŗ,Ā  Poland

A dedicated researcher and project leader at the Medical University of Lodz, Poland, with expertise in pharmacological characterization and anticancer drug development. As Principal Investigator and Co-investigator, led projects funded by prestigious grants like OPUS and SONATA, focusing on opioid peptide analogs and alpha-methylidene-delta-lactones. Supervising international student exchanges and engaging in expert activities, workshops, and editorial work. Recognized with numerous awards for scientific excellence, including Rector’s Awards and IF=8.638 for publication series on opioid mimetics and glutathione peroxidase. Committed to advancing medical science through innovative research and academic leadership.

Profile

  1. Scopus

 

  1. Orcid

šŸ“œ Employment History:

Research Associate (2017-present) Medical University of Lodz, Poland; Faculty of Medicine. Co-investigator (2016-2021)
Project: Rational design and pharmacological characterization of chimeric cyclic opioid peptide analogs targeting multiple receptors
Grant: OPUS 9, project ID 2015/17/B/ST5/00153. Principal Investigator (2016-2021) Project: Analysis of the anticancer activity of new synthetic alpha-methylidene-delta-lactones in selected cell lines Grant: SONATA, project ID 2015/17/D/NZ3/02226. Supervisor, Project Manager, and Principal Investigator (2018-present) Project: Analysis of the anticancer activity and molecular mechanism of action of new hybrid molecules containing uracil skeleton with an exo-cyclic methylene group Grant: PRELUDIUM13, project ID UMO-2017/25/N/NZ3/01039

šŸ“š Short Research Training:

University of Rouen, France (2014) Laboratoire de Neuropsychopharmacologie ExpƩrimentale

šŸŒ Activities:

  • Expert Activity/Reviewer (2024)
    Platform: Qeios
  • International Student Exchanges and ERASMUS Supervision (2024)
    Engaging in initiatives and participating in European Union programs, overseeing ERASMUS students.
  • Participation in Scientific Workshops and Research Teams (2024)
    Engaging in workshops aimed at exchanging experiences, self-improvement, and organization.
  • Editorial Work (2023-present)
    Journal: Reviewer for Breast Cancer-Tokyo, ISSN 1340-6868, eISSN 1880-4233.

šŸ† Awards and Distinctions:

2022: First-level Special Award for Outstanding Didactic Work by Academic Teachers Medical University of Lodz.

2020: Team Distinction from the Faculty of Chemistry Nicolaus Copernicus University in Toruń Rector’s Award Medical University of Lodz Second-degree scientific award for a series of publications titled: ‘Investigation of the Anticancer Properties of Synthetic Analogues of Compounds Isolated from Plants’. (Impact Factor – 8.034). Polish Intelligent Development Award – Nomination.

2019: Investigation of Anticancer Activity of Synthetic Analogues of Methylenolactones”, IF=4.026PTBioch Bursary Scholarship 44th FEBS Congress “From Molecules to Living Systems”. Rector’s Award Medical University of Lodz Second Prize for Publication: ‘Synthetic Analogues of Coumarin as Novel Agents with Anticancer Activity’. (Impact Factor = 4.173). Rector’s Award Medical University of Lodz Team Second award for Publication Series:

2017: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Synthesis and Investigation of Biological Activity of Opioid Mimetics and Glutathione Peroxidase”. (IF=8.638). Rector’s Award Medical University of Lodz Team First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Dicoumarins”. (IF=6.221) “Investigation of Anticancer Activity of Sesquiterpene Lactones”. (IF=4.994)

2016: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Lactones in Combination with Known Anticancer Drugs”. (IF = 8.835)

Publications Top Notes šŸ“

  • Title: Synthesis of New Chiral Ī²-Carbonyl Selenides with Antioxidant and Anticancer Activity Evaluation-Part I
    • Authors: Laskowska, A., Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., et al.
    • Journal: Materials
    • Year: 2024
    • Volume: 17
    • Pages: 1ā€“15
    • Summary: This study focuses on the synthesis of new chiral Ī²-carbonyl selenides and evaluates their antioxidant and anticancer activities, providing valuable insights into potential therapeutic agents.

 

  • Title: New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF7 Cancer Cells
    • Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
    • Journal: Biologics: Targets and Therapy
    • Year: 2023
    • Volume: 17
    • Pages: 69ā€“83
    • Summary: This article presents a novel uracil analog with potential to reverse resistance to Taxol in MCF7 cancer cells, indicating its promising role as an anticancer agent.

 

  • Title: New Uracil Analog- U-359 can Reverse Resistance to Taxol in MCF-7 cancer cells
    • Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
    • Journal: Acta Biochimica Polonica
    • Year: 2023
    • Volume: 70
    • Pages: 56
    • Summary: This study explores another uracil analog’s potential to reverse resistance to Taxol in MCF-7 cancer cells, indicating a promising avenue for further research.

 

  • Title: The Influence of Long Carbon Chains on the Antioxidant and Anticancer Properties of N-Substituted Benzisoselenazolones and Corresponding Diselenides
    • Authors: Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., Jastrzębska, A., et al.
    • Journal: Pharmaceuticals
    • Year: 2023
    • Volume: 16
    • Pages: 1ā€“11
    • Summary: This research investigates the impact of long carbon chains on the antioxidant and anticancer properties of N-substituted benzisoselenazolones and corresponding diselenides, providing valuable insights into structure-activity relationships.

 

  • Title: Attachment of Chiral Functional Groups to Modify the Activity of New GPx Mimetics
    • Authors: Laskowska, A., Pacuła-Miszewska, A., Długosz-Pokorska, A., et al.
    • Journal: Materials
    • Year: 2022
    • Volume: 16
    • Pages: 1ā€“14
    • Summary: This study explores the modification of GPx mimetics’ activity through the attachment of chiral functional groups, offering potential strategies for enhancing therapeutic effects.

 

Ebru Temiz | cancer research | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr . Ebru Temiz | cancer research | Best Researcher Award

šŸ‘Øā€šŸ«Profile Summary

A dedicated academic and researcher in the field of Medical Biology and Genetics, with extensive experience in cancer research and therapeutic investigations. Holds a Ph.D. and Master’s degree from Gaziantep University, specializing in miRNA and lncRNA therapies for cancer treatment. Currently serving as a faculty member at Harran University, contributing to educational programs and leading various research projects. Proficient in project management, molecular biology techniques, and data analysis. Passionate about advancing medical science and making meaningful contributions to cancer therapy.

šŸŒ Professional Profiles

šŸ“š Education Information

šŸŽ“ PhD in Medical Biology and Genetics Institution: Gaziantep University, Medical Faculty Department: Medical Biology and Genetics Thesis Title: Investigation of the Therapeutic Effects of miRNAs Targeting CCT3 Gene in Various Cancer Cell Lines Date: 01 September 2016 – 01 November 2020 (4 Years 3 Months) Thesis Advisor: Professor Emel Şahin šŸŽ“ Master’s Degree in Medical Biology and Genetics Institution: Gaziantep University, Medical Faculty Department: Medical Biology and Genetics Thesis Title: Investigation of the Therapeutic Effect of PINK1-AS lncRNA in HCT116 Colon Cancer Cell Line Date: 01 September 2013 – 01 June 2016 (2 Years 10 Months) Thesis Advisor: Professor Serdar Oztuzcu šŸŽ“ Bachelorā€™s Degree in Biology Institution: Gaziantep University Date: 01 September 2008 – 26 June 2012 (3 Years 10 Months) Cumulative Grade Point Average: 3.21 / 4.0

šŸ“ Experience Information

šŸ‘Øā€šŸ« Faculty Member, Dr. Institution: Harran University Şanlıurfa Health Services Vocational School Department: Medical Services and Techniques, Medical Promotion and Marketing Program Date: 07 September 2022 – Present (11 Months) šŸ‘Øā€šŸ« Faculty Member Institution: Harran University Şanlıurfa Health Services Vocational School Department: Medical Services and Techniques, Medical Promotion and Marketing Program Date: 09 March 2017 – Present (6 Years 5 Months) šŸ‘Øā€šŸ”¬ PhD Fellow Institution: Gaziantep University Date: 01 January 2013 – 01 January 2017 (4 Years 1 Month)

šŸ“š Competency

šŸ“– Books Title: Cancer Genetics Authors: E. Temiz, R. Dikme, A. Sarpkaya, D. Taşdemir, C. Okudu, . Bozgeyik & E. Bozgeyik Publication: Nobel Publication, Turkey Date: 01 December 2021 Chapter In Book

šŸ”¬ Projects

Investigation Of Mmh-1’s Anti-Cancer Effect In 4T1 Breast Cancer Mouse Model Position: Project Manager Institution: Harran University Sponsor Institution: Harran University (Domestic) Status: Ongoing Investigation Of The Protective Effects Of Green Pistachio (Pistacia Vera L.) Shell Extract On The Heart In Rats With Doxorubicin-Induced Cardiac Damage Position: Researcher Institution: Medical Faculty Sponsor Institution: Harran University (Domestic) Status: Ongoing Protective Effects Of Fusilin On Heart Damage Induced By Dobutamine In Rats Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Status: Ongoing Effects Of Myo-Inositol And Oxytetracycline Added To The Diluter On Sperm Quality After Thawing Of Frozen Sperm Of Barbus Grypus Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Status: Ongoing Investigation Of Therapeutic Effects Of miRNAs Targeting CCT3 Gene In Various Cancer Cell Lines Position: Researcher Institution: Gaziantep University Sponsor Institution: Gaziantep University (Domestic) Date: 01 May 2019 – 01 November 2020 Investigation Of The Potential Use Of Green Antep Pistachio Shell As A Phytotherapeutic And Dietary Supplement Product Position: Researcher Institution: Harran University Sponsor Institution: Development Ministry (Domestic) Date: 01 February 2019 – 01 May 2020 Evaluation Of Polymorphisms In CX3CR1, UQCC And BMP-2 Genes And miR-96 Expression In Patients With Developmental Hip Dysplasia (DHD) Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 October 2018 – 01 October 2019 Investigation Of The Anticancer Effect Of Haplophyllum Ptilostylum Plant On Liver Cancer (SNU-423) Cells Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 July 2018 – 01 February 2019 Change In Micro-RNA During Cardiopulmonary Bypass Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 February 2018 – 01 February 2019 Investigation Of Tissue And Plasma Free Amino Acid And Carnitine Profile In Patients With Pterygium Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 January 2018 – 01 January 2019 Equation With Three Unknowns In The Pericardial Fluid And Plasma Of Patients Undergoing Open Heart Surgery: Interleukin 33 (IL33), Fetuin A, And Cytokeratin 18 Relationship Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 February 2017 – 01 April 2018

šŸ“šTop Noted Publication

  1. Title: Cardioprotective Effect Of Pistacia Vera L.(Green Pistachio) Hull Extract In Wistar Albino Rats With Doxorubicin-Induced Cardiac Damage
    • Authors: Ersƶz, M. S., Aydin, Y., Hacanli, N., KankiliƧ, N., Koyuncu, ., GĆ¼ldĆ¼r, M. E., Temiz, E., Ƈakmak, Y., Eč, K., Dikme, R., Padak, M.
    • Journal: Anatolian Journal Of Cardiology
    • Year: 2023
    • Volume: 27
    • Issue: 3
    • Pages: 2149-2263

 

  1. Title: Local Myelin Damage In The Hippocampus Fluctuates Gut Microbiome Profile And Memory
    • Authors: Bostancıoğlu, M., Kaplan, D. S., Temiz, E., Y, G. T.
    • Journal: Journal Of Psychiatric Research
    • Year: 2023
    • Volume: 158
    • Pages: 392-402

 

  1. Title: Novel Zinc Oxide Nanoparticles Of Teucrium Polium Suppress The Malignant Progression Of Gastric Cancer Cells Through Modulating Apoptotic Signaling Pathways And Epithelial To Mesenchymal Transition
    • Authors: Elmastaş, E., Temiz, E., Koyuncu, ., Erdal, B., Koyuncu, ., Tem Z, C., Bozgeyik, E.
    • Journal: Gene
    • Year: 2023
    • Volume: 853
    • Pages: 147091

 

  1. Title: Protective Effects Of Fuziline On Dobutamine-Induced Heart Damage In Mice
    • Authors: Hacanli, Y., Aydin, M. S., Ersƶz, E. K., KankiliƧ, N., Koyuncu, ., GĆ¼ldĆ¼r, M. E., Temiz, E., Dikme, R., Eč, K., Ƈakmak, Y., Padak, M.
    • Journal: Brazilian Journal Of Cardiovascular Surgery
    • Year: 2023
    • Volume: 38
    • Issue: 1
    • Pages: E20220251

 

  1. Title: Asprosin And Oxidative Stress Level In Covid-19 Patients
    • Authors: Seyhanlı, E. S., Koyuncu, I., Yasak, I. H., Dem, H. R., Temiz, E.
    • Journal: Clinical Laboratory
    • Year: 2022
    • Volume: 68
    • Issue: 1
    • Pages: 1-6

 

  1. Title: Cedrus Libani Tar Prompts Reactive Oxygen Species Toxicity And Dna Damage In Colon Cancer Cells
    • Authors: Temiz, E., Eg, K., Koyuncu, I., Yuksekdag, O., Kurt, Y., Ken, M. T., Akmese, S.
    • Journal: Molecular Biology Reports
    • Year: 2022
    • Volume: –
    • Pages: –
    • DOI: 0301-4851

 

  1. Title: Examination Of Carnitine Metabolism In Different Breast Cancer Cell Lines
    • Authors: Akmeşe, Ş., Temiz, E., Koyuncu, ., Taşkıran, H., TĆ¼ysĆ¼z, M. Z.
    • Journal: Harran University Medical Faculty Journal
    • Year: 2022
    • Volume: 19
    • Issue: 1
    • Pages: 1-7

 

  1. Title: Intracellular Ph-Mediated Induction Of Apoptosis In Hela Cells By A Sulfonamide Carbonic Anhydrase Inhibitor
    • Authors: Koyuncu, I., Temiz, E., Durgun, M., Kocy G T, A., Yuksekdag, O., Supuran, C. T.
    • Journal: International Journal Of Biological Macromolecules
    • Year: 2022
    • Volume: 201
    • Pages: 37-46

 

  1. Title: Examination Of The Anticancer Activity Of Pecan (Carya Illinoensis) Shell
    • Authors: Akkafa, F., Hayırlı, Z., Temiz, E., Koyuncu, .
    • Journal: Harran University Medical Faculty Journal
    • Year: 2022
    • Volume: 19
    • Issue: 1
    • Pages: 131-136

 

  1. Title: Silencing Of Tp73-As1 Impairs Prostate Cancer Cell Proliferation And Induces Apoptosis Via Regulation Of Tp73
  • Authors: Arslan, A., Batar, B., Temiz, E., Tozk R, H., Koyuncu, I., Bozgeyik, E.
  • Journal: Molecular Biology Reports
  • Year: 2022
  • Volume: 49
  • Issue: 7
  • Pages: 6859-6869